showed a trendp=0.07
Z-100 showed a trend of OS improvement compared with placebo (5-year OS rate, 75.7% vs. 6.58%; HR, 0.65; 95% CI, 0.40 to 1.04; p=0.07) regardless of whether the cohort received chemoradiation or radiotherapy alone.
Z-100 showed a trend of OS improvement compared with placebo (5-year OS rate, 75.7% vs. 6.58%; HR, 0.65; 95% CI, 0.40 to 1.04; p=0.07) regardless of whether the cohort received chemoradiation or radiotherapy alone.